The International Energy Agency (IEA) revealed in its report that solar energy is now one of the cheapest sources of electricity due to maturing technologies and policies that have reduced the cost of investments.
The IEA's report said that electricity costs from large-scale solar photovoltaic installations had dropped significantly from 38 cents per kilowatt-hour in 2010 to 6.8 cents per kilowatt-hour last year.
The prospects for increasing renewable energy generation could range from strong to spectacular, with solar leading the way.
Photovoltaic systems can be easily be installed as panels on homes or businesses, as well as deployed at solar parks.
IEA executive director Fatih Birol said that she sees solar becoming the new king of electricity markets and is on track to set new records for deployment every year after 2022.
According to the IEA, solar power remains a cost-effective choice even if the pandemic drags on and cause lasting damage to the economy.
Under the IEA's "Sustainable Development Scenario," where an increase in clean energy policies and investment puts the world on track to reach the goals of the Paris Climate Agreement, the combined share of solar photovoltaic and wind surges from 8 percent in 2019 to almost 30 percent in 2030.


Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
OpenAI Tightens AI Safety Monitoring After Security Incidents
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Standard Chartered Expands Hedge Fund Access for Wealth Clients 



